[1] Curran M E, Splawski I, Timothy K W, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome[J]. Cell, 1995,80(5):795-803.[2] Warmke W, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals[J]. Proc Natl Acad Sci USA, 1994,91(8):3438-3442.[3] Hardy A B, Fox J E, Giglou P R, et al. Characterization of Erg K+ channels in α- and β-Cells of mouse and human islets[J]. J Biol Chem, 2009,284(44):30441-30452.[4] Einarsen K, Calloe K, Grunnet M, et al. Functional properties of human neuronal Kv11 channels[J]. Pflugers Arch, 2009,458(4):689-700.[5] Humphrev P P, Bunce K T. Tachycardia during cisapride treatment[J]. BMJ, 1992,305(6860):1019-1020.[6] Bran S, Murray W A, Hirsh I B, et al. Long QT syndrome during high-dose cisapride[J]. Arch Intern Med, 1995,155(7):765-768.[7] Wysowski D K, Bacsanyi J. Cisapride and fatal arrhythmia[J]. N Engl J Med, 1996, 335(4):290-291.[8] Mohammad S, Zhou Z, Gong Q, et al. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride[J]. Am J Physiol, 1997,273(5 Pt 2):H2534-H2538.[9] Shibasaki T. Conductance and kinetics of delayed rectifierpotassium channels in nodal cells of the rabbit heart[J]. J Physiol, 1987,387:227-250.[10] Zhou Z, Gong Q, Ye B, et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature[J]. Biophys J, 1998,74(1):230-241.[11] Shi W, Wymore R S, Wang H S, et al. Identification of two nervous system-specific members of the erg potassium channel gene family[J]. J Neurosc, 1997,17(24):9423-9432.[12] Snyders D J, Chaudhary A. High affinity open channel block by dofetilide of HERG expressed in a human cell line[J]. Mol Pharrnacol, 1996,49(6):949-955.[13] Elmedyb P, Olesen S P, Grunnet M. Activation of ERG2 potassium channels by the diphenylurea NS1643[J]. Neuropharmacology, 2007,53(2):283-294. |